Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
March 3, 2026
Cerebrospinal fluid mitochondrial DNA reflects body composition and energy metabolism in Parkinson's disease
YM
Yasuaki Mizutani
Fujita Health University
RN
Ryunosuke Nagao
Fujita Health University
KK
Kazuya Kawabata
Fujita Health University
Ver todo
Puntos clave
Cerebrospinal fluid mitochondrial DNA levels correlate with body composition and energy metabolism in Parkinson's disease.
Higher mitochondrial DNA levels appear linked to better energy metabolism, indicating potential biomarkers.
Observational analysis reveals significant associations between mitochondrial DNA and body weight in Parkinson's patients.
Findings suggest mitochondrial DNA may serve as a biological marker for monitoring disease progression in Parkinson's.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cerebrospinal fluid mitochondrial DNA reflects body composition and energy metabolism in Parkinson's disease | Synapse
Cite This Study
Copy
Mizutani et al. (Mon,) studied this question.
synapsesocial.com/papers/69a75f43c6e9836116a2a843
https://doi.org/https://doi.org/10.1016/j.jns.2025.125288